Literature DB >> 31409638

Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer.

Tingting Yang1, Chune Ren1, Chao Lu1, Pengyun Qiao1, Xue Han1, Li Wang1, Dan Wang2, Shijun Lv2, Yonghong Sun2, Zhenhai Yu3.   

Abstract

Heat shock transcription factor 1 (HSF1) is the master regulator of the proteotoxic stress response, which plays a key role in breast cancer tumorigenesis. However, the mechanisms underlying regulation of HSF1 protein stability are still unclear. Here, we show that HSF1 protein stability is regulated by PIM2-mediated phosphorylation of HSF1 at Thr120, which disrupts the binding of HSF1 to the E3 ubiquitin ligase FBXW7. In addition, HSF1 Thr120 phosphorylation promoted proteostasis and carboplatin-induced autophagy. Interestingly, HSF1 Thr120 phosphorylation induced HSF1 binding to the PD-L1 promoter and enhanced PD-L1 expression. Furthermore, HSF1 Thr120 phosphorylation promoted breast cancer tumorigenesis in vitro and in vivo. PIM2, pThr120-HSF1, and PD-L1 expression positively correlated with each other in breast cancer tissues. Collectively, these findings identify PIM2-mediated HSF1 phosphorylation at Thr120 as an essential mechanism that regulates breast tumor growth and potential therapeutic target for breast cancer. SIGNIFICANCE: These findings identify heat shock transcription factor 1 as a new substrate for PIM2 kinase and establish its role in breast tumor progression. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31409638     DOI: 10.1158/0008-5472.CAN-19-0063

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance.

Authors:  Chune Ren; Xue Han; Chao Lu; Tingting Yang; Pengyun Qiao; Yonghong Sun; Zhenhai Yu
Journal:  Cell Death Differ       Date:  2021-08-31       Impact factor: 12.067

Review 2.  Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy.

Authors:  Liangliang Xing; Leidi Xu; Yong Zhang; Yinggang Che; Min Wang; Yongxiang Shao; Dan Qiu; Honglian Yu; Feng Zhao; Jian Zhang
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

3.  Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis.

Authors:  Xue Han; Chune Ren; Chao Lu; Pengyun Qiao; Tingting Yang; Zhenhai Yu
Journal:  Cell Death Differ       Date:  2022-03-16       Impact factor: 12.067

Review 4.  Molecular Mechanisms of Heat Shock Factors in Cancer.

Authors:  Mikael Christer Puustinen; Lea Sistonen
Journal:  Cells       Date:  2020-05-12       Impact factor: 6.600

Review 5.  Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy.

Authors:  Chul Won Yun; Hyung Joo Kim; Ji Ho Lim; Sang Hun Lee
Journal:  Cells       Date:  2019-12-24       Impact factor: 6.600

Review 6.  Progress of Breast Cancer basic research in China.

Authors:  Xuerong Wang; Chao Wang; Jiaheng Guan; Baoan Chen; Lin Xu; Ceshi Chen
Journal:  Int J Biol Sci       Date:  2021-05-11       Impact factor: 6.580

7.  Expression Characteristics and Significant Prognostic Values of PGK1 in Breast Cancer.

Authors:  Yanping Li; Shanshan Wang; Xiaoyuan Zhang; Rui Yang; Xiaonan Wei; Ruirong Yan; Yaru Jiang; Wenzhi Shen
Journal:  Front Mol Biosci       Date:  2021-07-05

8.  Pan-Cancer Analysis of the Prognostic and Immunological Role of HSF1: A Potential Target for Survival and Immunotherapy.

Authors:  Fei Chen; Yumei Fan; Pengxiu Cao; Bing Liu; Jiajie Hou; Bo Zhang; Ke Tan
Journal:  Oxid Med Cell Longev       Date:  2021-06-18       Impact factor: 6.543

9.  Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation.

Authors:  Chao Lu; Chune Ren; Tingting Yang; Yonghong Sun; Pengyun Qiao; Xue Han; Zhenhai Yu
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

10.  β-catenin represses miR455-3p to stimulate m6A modification of HSF1 mRNA and promote its translation in colorectal cancer.

Authors:  Ping Song; Lifeng Feng; Jiaqiu Li; Dongjun Dai; Liyuan Zhu; Chaoqun Wang; Jingyi Li; Ling Li; Qiyin Zhou; Rongkai Shi; Xian Wang; Hongchuan Jin
Journal:  Mol Cancer       Date:  2020-08-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.